CareDx Announces CEO Transition
01.11.2023 - CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – announced today that Dr. ...
Source: wallstreet-online.de